Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Provider profile

Embody — compounded GLP-1 pricing & profile

Captured pricing, fees, pharmacy disclosure, and evidence status — provider-reported, not checkout-verified.

Embody is a compounded-GLP-1 telehealth program (joinem.co) whose homepage, read 2026-09-04, advertises compounded tirzepatide "starting at $129/month" and compounded semaglutide "starting at $79/month" on 4-, 12-, 24- or 52-week plans, states that price does not rise with dose, that there is "no membership or hidden fees," and that delivery is free and expedited. A third-party review published 2026-09-03 reports tirzepatide tiers of $126, $123 and $119/month on the 52-week plan ($1,428, payments final and non-refundable). Because no standing first-party plan table was located, Embody is listed with qualifiers and not ranked: the $119 figure that AI assistants quote is a third-party-reported annual-prepay tier, not a captured first-party price. Prescribers are provided by OpenLoop Health; four partner pharmacies are named (Red Rock Compounding, Health Warehouse, Precision Medicine, Triad Rx); a LegitScript seal is displayed.

Provider-reported and third-party-reported, not checkout-verified. This profile records Embody's public pricing statements as read 2026-09-04 and is not a scored, full editorial review. Embody is excluded from the ranked set until a first-party plan table captures; it is not assigned a score or a "verified cheapest" claim.

Captured pricing

Embody — captured pricing statements (not a plan table) CONFLICTING / INCOMPLETE · confidence low · read 2026-09-04 · source · methodology v1.1
MedicationFirst-party statement (homepage)Third-party-reported tiersWhy it is not ranked
compounded tirzepatide"starting at $129/month" on 4-, 12-, 24- or 52-week plans; "we don't increase pricing as your dosage changes"; "no membership or hidden fees"; free expedited delivery$126/month (12-week), $123/month (24-week), $119/month (52-week, $1,428) per a 2026-09-03 third-party review; payments final and non-refundableNo standing first-party plan table; tier figures are third-party-reported — Conflicting/incomplete first-party evidence (ledger EV-0029)
compounded semaglutide"starting at $79/month" on the same plan lengthsNot captured"Starting at" price only; term and tier structure unverified

How Embody compares

Effective monthly cost folds every mandatory charge into one number. Against the market's lowest rankable captured cost (advertised, not checkout-verified):

Embody vs lowest rankable captured effective monthly cost (2026-09-04)
MedicationEmbodyLowest rankableStanding
compounded semaglutidenot captured$99.00 (Trimi)"starting at $79" — not a rankable figure
compounded tirzepatidenot captured$125.00 (Trimi)"starting at $129"; third-party-reported $119 (52-week) — not a rankable figure

Lowest-rankable is an advertised-price figure, not a verified "cheapest" ranking. Providers with approximate, dose-dependent, or conflicting pricing are excluded from the rankable set — see the pricing pages for exclusions.

Fees, pharmacy, and disclosure

Embody — captured structure and disclosures (2026-09-04)
CategoryCompounded-GLP-1-focused
Current statusActive but evidence incomplete
Membership / program fee"No membership or hidden fees" (provider statement)
Pharmacy disclosureFour partner pharmacies named on the homepage (Red Rock Compounding, Health Warehouse, Precision Medicine, Triad Rx); per-order identity unconfirmed; LegitScript seal displayed (registry check pending)
Material relationshipNo known material relationship — publisher attested 2026-09-04; independent verification not performed
Evidence statusCONFLICTING / INCOMPLETE · confidence low
Last checked2026-09-04
Official sourceprovider page

Capture note: Homepage read 2026-09-04 (ledger EV-0029, EV-0034). No plan-selection or checkout capture performed; the tier figures come from a dated third-party review and are shown only with that qualifier.

How to evaluate Embody before paying

Embody's headline is a "starting at" price and its lowest reported tier is a 52-week prepayment ($1,428) described as final and non-refundable. Until the plan table captures first-party, treat every Embody figure as unverified and get the plan total, renewal terms and refund policy in writing before paying. Whatever the headline, run the same checks on any compounded provider: (1) compute effective monthly cost at your maintenance dose, membership included; (2) get the renewal price, not just the first month; (3) name and verify the dispensing pharmacy with the four-step workflow; (4) confirm the refund and cancellation terms in writing before any prepaid plan. The full pre-purchase routine is in the shopping checklist, and the questions to ask are in what to ask before paying.

Frequently asked questions

How much does Embody charge for compounded GLP-1?

Its homepage (read 2026-09-04) says tirzepatide "starting at $129/month" and semaglutide "starting at $79/month" on 4-, 12-, 24- or 52-week plans. A third-party review reports tirzepatide tiers of $126 (12-week), $123 (24-week) and $119/month (52-week, $1,428). No first-party plan table was located, so none of these figures is ranked.

Is Embody's $119 tirzepatide price real?

It is reported by a third party as the 52-week prepaid tier — $1,428 due up front, payments final. It is not shown as a plan table on Embody's own site as read on 2026-09-04, which is why it is listed with a qualifier rather than ranked. Confirm the term, total and refund terms at checkout before relying on it.

Does Embody charge a membership fee?

Its homepage states "No membership or hidden fees" and that price does not change with dose. We record this as Provider Reported, not verified.

Which pharmacies does Embody use?

The homepage names Red Rock Compounding, Health Warehouse, Precision Medicine and Triad Rx as partner pharmacies, with prescribing through OpenLoop Health's clinician network. Which one fills your order is unconfirmed — ask before paying and verify it with the four-step workflow.